Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Shockwave Medical, Inc. (SWAV) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 144 Form 144 - Report of proposed sale of securities:
08/23/2023 144 Form 144 - Report of proposed sale of securities:
08/22/2023 144 Form 144 - Report of proposed sale of securities:
08/21/2023 144 Form 144 - Report of proposed sale of securities:
08/15/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Indenture between Shockwave Medical, Inc. and U.S. Bank Trust Company, National Association, as trustee (including the form of 1.00% Convertible Senior Notes due 2028)",
"Form of Capped Call Transaction Confirmation"
08/10/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"SHOCKWAVE MEDICAL PRICES UPSIZED PRIVATE OFFERING OF $650.0 MILLION OF 1.00% CONVERTIBLE SENIOR NOTES DUE 2028"
08/10/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"SHOCKWAVE MEDICAL ANNOUNCES PROPOSED PRIVATE OFFERING OF $500.0 MILLION OF CONVERTIBLE SENIOR NOTES"
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/07/2023 8-K Quarterly results
Docs: "Shockwave Medical Reports Second Quarter 2023 Financial Results SANTA CLARA, Calif., Aug. 07, 2023 -- Shockwave Medical, Inc. , a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today reported financial results for the three months ended June 30, 2023. Recent Highlights Recognized revenue of $180.2 million for the second quarter of 2023, representing an increase of 49% from the same period in 2022 As part of the Fiscal Year 2024 Medicare Hospital Inpatient Prospective Payment System final rule, the Centers for Medicare & Medicaid Services created three new coronary IVL-specific MS-DRGs, which will become effective October 1, 2023. These new codes are associated with higher payments than the MS-DRG payments for o..."
07/25/2023 144 Form 144 - Report of proposed sale of securities:
07/20/2023 144 Form 144 - Report of proposed sale of securities:
06/01/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "SECOND AMENDMENT TO OFFICE LEASE"
05/26/2023 SD Form SD - Specialized disclosure report:
05/25/2023 144 Form 144 - Report of proposed sale of securities:
05/17/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/17/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "SHOCKWAVE APPOINTS KEVIN BALLINGER TO BOARD OF DIRECTORS"
05/11/2023 144 Form 144 - Report of proposed sale of securities:
05/11/2023 144 Form 144 - Report of proposed sale of securities:
05/08/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/08/2023 8-K Quarterly results
Docs: "Shockwave Medical Reports First Quarter 2023 Financial Results SANTA CLARA, Calif., May 08, 2023 -- Shockwave Medical, Inc. , a pioneer in the development and commercialization of Intravascular Lithotripsy to treat complex calcified cardiovascular disease, today reported financial results for the three months ended March 31, 2023. Recent Highlights Recognized revenue of $161.1 million for the first quarter of 2023, representing an increase of 72% from the same period in 2022 Announced the full U.S. commercial availability of the Shockwave L 6 Peripheral IVL Catheter following clearance by the U.S. Food and Drug Administration Centers for Medicare & Medicaid Services , as part of the calendar year 2024 Medicare Hospital Inpatient Prospective Payment System proposed rule, proposed three newl..."
04/26/2023 144 Form 144 - Report of proposed sale of securities:
04/21/2023 ARS Form ARS - Annual Report to Security Holders:
04/21/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/21/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/20/2023 144 Form 144 - Report of proposed sale of securities:
04/19/2023 144 Form 144 - Report of proposed sale of securities:
04/19/2023 144 Form 144 - Report of proposed sale of securities:
02/27/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
02/27/2023 10-K Annual Report for the period ended December 31, 2022
02/14/2023 5 MOLL FREDERIC H (Director) has filed a Form 5 on Shockwave Medical, Inc.
02/14/2023 5 FRANCIS LAURA (Director) has filed a Form 5 on Shockwave Medical, Inc.
02/14/2023 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 2.8% stake in SHOCKWAVE MEDICAL INC
02/09/2023 SC 13G/A FMR LLC reports a 8.5% stake in SHOCKWAVE MEDICAL INC
01/23/2023 SC 13G/A BlackRock Inc. reports a 12.7% stake in ShockWave Medical, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy